BDBM106472 US8586579, 61

SMILES O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1

InChI Key InChIKey=YGCYKAKZEZYUMC-NJDAHSKKSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 106472   

Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM106472(US8586579, 61)
Affinity DataKi:  11.8nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM106472(US8586579, 61)
Affinity DataKi:  18.7nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM106472(US8586579, 61)
Affinity DataKi:  1.12E+3nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In DepthDetails US Patent